09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3515<br />
MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
(51) (97) (54)<br />
A61P 25/18 (2006.01) EP 2086643 * COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE<br />
A61P 25/18 (2006.01) EP 2089011 * TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS<br />
A61P 25/18 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR<br />
ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT<br />
A61P 25/18 (2006.01) EP 2<strong>09</strong>1938 * PIPERIDINYLAMINO-PYRIDAZINES AND THEIR USE AS FAST DISSOCIATING DOPAMINE<br />
2 RECEPTOR ANTAGONISTS<br />
A61P 25/18 (2006.01) EP 2<strong>09</strong>4657 * AZABICYCLIC COMPOUNDS AS SEROTONINE, DOPAMINE AND NOREPINEPHRINE RE-<br />
UPTAKE INHIBITORS<br />
A61P 25/18 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />
A61P 25/18 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />
A61P 25/20 (2006.01) EP 2089382 * SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS<br />
A61P 25/20 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />
A61P 25/22 (2006.01) EP 2<strong>09</strong>47<strong>09</strong> * THIAZOLE PYRAZOLOPYRIMIDINES AS CRF1 RECEPTOR ANTAGONISTS<br />
A61P 25/22 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />
A61P 25/22 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />
A61P 25/22 (2006.01) EP 2<strong>09</strong>9444 * USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS<br />
A61P 25/24 (2006.01) EP 2089011 * TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS<br />
A61P 25/24 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR<br />
ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT<br />
A61P 25/24 (2006.01) EP 2<strong>09</strong>1939 * COMPOUNDS WITH A COMBINATION OF CANNABINOID-CB1 ANTAGONISM AND<br />
ACETYLCHOLINESTERASE INHIBITION<br />
A61P 25/24 (2006.01) EP 2<strong>09</strong>47<strong>09</strong> * THIAZOLE PYRAZOLOPYRIMIDINES AS CRF1 RECEPTOR ANTAGONISTS<br />
A61P 25/24 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />
A61P 25/24 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>0310 * ADHESIVE PREPARATION, AND METHOD FOR REDUCING THE PRODUCTION OF<br />
DONEPEZIL ANALOGUE IN DONEPEZIL-CONTAINING SKIN ADHESIVE PREPARATION<br />
METHOD FOR PREVENTION OF COLORATION IN DONEPEZIL-CONTAINING SKIN<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>1531 * PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING<br />
DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>1534 * AZETIDINONE DERIVATIVES AND METHODS OF USE THEREOF<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>1939 * COMPOUNDS WITH A COMBINATION OF CANNABINOID-CB1 ANTAGONISM AND<br />
ACETYLCHOLINESTERASE INHIBITION<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>7079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>7372 * PROCESS FOR THE PREPARATION OF MEMANTINE AND ITS HYDROCHLORIC ACID<br />
SALT FORM<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>8232 * PERCUTANEOUS ABSORPTION PREPARATION<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>8234 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />
CONTAINING SKIN ADHESIVE PREPARATION<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>85<strong>09</strong> * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />
A61P 25/28 (2006.01) EP 2<strong>09</strong>9768 * AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE RECEPTOR<br />
A61P 25/30 (2006.01) EP 2<strong>09</strong>1939 * COMPOUNDS WITH A COMBINATION OF CANNABINOID-CB1 ANTAGONISM AND<br />
ACETYLCHOLINESTERASE INHIBITION<br />
A61P 25/30 (2006.01) EP 2<strong>09</strong>47<strong>09</strong> * THIAZOLE PYRAZOLOPYRIMIDINES AS CRF1 RECEPTOR ANTAGONISTS<br />
A61P 27/00 (2006.01) EP 2086530 * USE OF GABAPENTIN AND PREGABALIN PRODRUGS FOR TREATING TINNITUS<br />
A61P 27/02 (2006.01) EP 2<strong>09</strong>1529 * USE OF L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT IN THE FORM OF<br />
EYE-DROPS FOR TREATING CORNEAL DISEASES<br />
A61P 27/02 (2006.01) EP 2<strong>09</strong>7455 * HUMANIZED ANTI-FACTOR D ANTIBODIES<br />
A61P 27/16 (2006.01) EP 2086530 * USE OF GABAPENTIN AND PREGABALIN PRODRUGS FOR TREATING TINNITUS<br />
A61P 29/00 (2006.01) EP 2014653 Novel dicarboxylic acid derivatives as S1P1 receptor agonists<br />
A61P 29/00 (2006.01) EP 2086942 * NOVEL COMPOUNDS<br />
A61P 29/00 (2006.01) EP 2089350 * CRYSTALLINE POTASSIUM SALT OF LIPOXIN A4 ANALOGS<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4640 * ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF<br />
THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4646 * AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED<br />
DISEASES<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4653 * O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS TRPV1 RECEPTOR ANTAGONISTS<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4671 * HETEROBICYCLIC METALLOPROTEASE INHIBITORS<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4688 * HETEROCYCLIC COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4697 * 5-SULFANYLMETHYL-PYRAZOLO [1,5-A]PYRIMIDIN-7-OL DERIVATIVES AS CXCR2<br />
ANTAGONISTS<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4701 * COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>4707 * HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS<br />
A61P 29/00 (2006.01) EP 2<strong>09</strong>47<strong>09</strong> * THIAZOLE PYRAZOLOPYRIMIDINES AS CRF1 RECEPTOR ANTAGONISTS<br />
ISSN 1331-2030
Change language